As posted by the BBC, EMA has made their decisions on where to locate the European Medicines Agency (EMA) and European Banking Agency, because of the need to relocate once Britain leaves the European Union (aka Brexit). Amsterdam will be the new host city for the EMA, with permanent office space becoming available around August of 2019, with temporary space being available sooner. Paris will get the Banking agency.
Although I had my hopes for Barcelona, Amsterdam is an outstanding choice: it was EMA’s own preference, because of the ability to retain most of their current employees: it’s not unreasonable to commute – at least for the weekdays – back and forth between London and Amsterdam. According to assessment information that EMA released last week, Amsterdam has additional benefits of being largely English-speaking, with education and health care on the order of what EMA staff would expect in the UK, as well as providing high-tech communications and a transportation hub close in to the city.
The relocation of the EMA is putting a crimp in many of EMA’s projects: IDMP is the only project with a schedule designed to span the move, and even there it’s expected there will be some delays. Contact ACUTA to help you plan your transition to IDMP, and to help you prepare for regulatory submissions to EMA.